Literature DB >> 22539578

Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.

S Barral1, T Bird, A Goate, M R Farlow, R Diaz-Arrastia, D A Bennett, N Graff-Radford, B F Boeve, R A Sweet, Y Stern, R S Wilson, T Foroud, J Ott, R Mayeux.   

Abstract

OBJECTIVE: Several genome-wide association studies (GWAS) have associated variants in late-onset Alzheimer disease (LOAD) susceptibility genes; however, these single nucleotide polymorphisms (SNPs) have very modest effects, suggesting that single SNP approaches may be inadequate to identify genetic risks. An alternative approach is the use of multilocus genotype patterns (MLGPs) that combine SNPs at different susceptibility genes.
METHODS: Using data from 1,365 subjects in the National Institute on Aging Late-Onset Alzheimer's Disease Family Study, we conducted a family-based association study in which we tabulated MLGPs for SNPs at CR1, BIN1, CLU, PICALM, and APOE. We used generalized estimating equations to model episodic memory as the dependent endophenotype of LOAD and the MLGPs as predictors while adjusting for sex, age, and education.
RESULTS: Several genotype patterns influenced episodic memory performance. A pattern that included PICALM and CLU was the strongest genotypic profile for lower memory performance (β = -0.32, SE = 0.19, p = 0.021). The effect was stronger after addition of APOE (p = 0.016). Two additional patterns involving PICALM, CR1, and APOE and another pattern involving PICALM, BIN1, and APOE were also associated with significantly poorer memory performance (β = -0.44, SE = 0.09, p = 0.009 and β = -0.29, SE = 0.07, p = 0.012) even after exclusion of patients with LOAD. We also identified genotype pattern involving variants in PICALM, CLU, and APOE as a predictor of better memory performance (β = 0.26, SE = 0.10, p = 0.010).
CONCLUSIONS: MLGPs provide an alternative analytical approach to predict an individual's genetic risk for episodic memory performance, a surrogate indicator of LOAD. Identifying genotypic patterns contributing to the decline of an individual's cognitive performance may be a critical step along the road to preclinical detection of Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539578      PMCID: PMC3345618          DOI: 10.1212/WNL.0b013e3182553c48

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

1.  Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease.

Authors:  D Fallin; A Cohen; L Essioux; I Chumakov; M Blumenfeld; D Cohen; N J Schork
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

2.  Trimming, weighting, and grouping SNPs in human case-control association studies.

Authors:  J Hoh; A Wille; J Ott
Journal:  Genome Res       Date:  2001-12       Impact factor: 9.043

3.  Statistical interaction in human genetics: how should we model it if we are looking for biological interaction?

Authors:  Xuefeng Wang; Robert C Elston; Xiaofeng Zhu
Journal:  Nat Rev Genet       Date:  2010-11-23       Impact factor: 53.242

4.  Complex adaptive systems and human health: the influence of common genotypes of the apolipoprotein E (ApoE) gene polymorphism and age on the relational order within a field of lipid metabolism traits.

Authors:  K E Zerba; R E Ferrell; C F Sing
Journal:  Hum Genet       Date:  2000-11       Impact factor: 4.132

5.  Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study.

Authors:  Robert S Wilson; Sandra Barral; Joseph H Lee; Sue E Leurgans; Tatiana M Foroud; Robert A Sweet; Neill Graff-Radford; Thomas D Bird; Richard Mayeux; David A Bennett
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Physical activity and Alzheimer disease course.

Authors:  Nikolaos Scarmeas; Jose A Luchsinger; Adam M Brickman; Stephanie Cosentino; Nicole Schupf; Ming Xin-Tang; Yian Gu; Yaakov Stern
Journal:  Am J Geriatr Psychiatry       Date:  2011-05       Impact factor: 4.105

7.  Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels.

Authors:  John S K Kauwe; Carlos Cruchaga; Sarah Bertelsen; Kevin Mayo; Wayne Latu; Petra Nowotny; Anthony L Hinrichs; Anne M Fagan; David M Holtzman; Alison M Goate
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.

Authors:  Carlos Cruchaga; John S K Kauwe; Kevin Mayo; Noah Spiegel; Sarah Bertelsen; Petra Nowotny; Aarti R Shah; Richard Abraham; Paul Hollingworth; Denise Harold; Michael M Owen; Julie Williams; Simon Lovestone; Elaine R Peskind; Ge Li; James B Leverenz; Douglas Galasko; John C Morris; Anne M Fagan; David M Holtzman; Alison M Goate
Journal:  PLoS Genet       Date:  2010-09-16       Impact factor: 5.917

9.  CR1 is associated with amyloid plaque burden and age-related cognitive decline.

Authors:  Lori B Chibnik; Joshua M Shulman; Sue E Leurgans; Julie A Schneider; Robert S Wilson; Dong Tran; Cristin Aubin; Aron S Buchman; Christopher B Heward; Amanda J Myers; John A Hardy; Matthew J Huentelman; Jason J Corneveaux; Eric M Reiman; Denis A Evans; David A Bennett; Philip L De Jager
Journal:  Ann Neurol       Date:  2011-03-09       Impact factor: 10.422

10.  Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.

Authors:  Ellen M Wijsman; Nathan D Pankratz; Yoonha Choi; Joseph H Rothstein; Kelley M Faber; Rong Cheng; Joseph H Lee; Thomas D Bird; David A Bennett; Ramon Diaz-Arrastia; Alison M Goate; Martin Farlow; Bernardino Ghetti; Robert A Sweet; Tatiana M Foroud; Richard Mayeux
Journal:  PLoS Genet       Date:  2011-02-17       Impact factor: 5.917

View more
  39 in total

1.  Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up.

Authors:  Jessica R Marden; Elizabeth R Mayeda; Stefan Walter; Alexandre Vivot; Eric J Tchetgen Tchetgen; Ichiro Kawachi; M Maria Glymour
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

Review 2.  Impact of late-onset Alzheimer's genetic risk factors on beta-amyloid endocytic production.

Authors:  Cláudia Guimas Almeida; Farzaneh Sadat Mirfakhar; Catarina Perdigão; Tatiana Burrinha
Journal:  Cell Mol Life Sci       Date:  2018-04-27       Impact factor: 9.261

Review 3.  Genome-wide association studies in neurology.

Authors:  Meng-Shan Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2014-12

4.  Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study.

Authors:  A Vivot; M M Glymour; C Tzourio; P Amouyel; G Chêne; C Dufouil
Journal:  Mol Psychiatry       Date:  2015-06-02       Impact factor: 15.992

Review 5.  The Role of PICALM in Alzheimer's Disease.

Authors:  Wei Xu; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2014-09-04       Impact factor: 5.590

6.  Bin1 and CD2AP polarise the endocytic generation of beta-amyloid.

Authors:  Florent Ubelmann; Tatiana Burrinha; Laura Salavessa; Ricardo Gomes; Cláudio Ferreira; Nuno Moreno; Cláudia Guimas Almeida
Journal:  EMBO Rep       Date:  2016-11-28       Impact factor: 8.807

7.  Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle.

Authors:  Shraddha Sapkota; Lars Bäckman; Roger A Dixon
Journal:  Neurobiol Aging       Date:  2017-01-03       Impact factor: 4.673

Review 8.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

9.  Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

10.  Genetic Analysis of Association Between Calcium Signaling and Hippocampal Activation, Memory Performance in the Young and Old, and Risk for Sporadic Alzheimer Disease.

Authors:  Angela Heck; Matthias Fastenrath; David Coynel; Bianca Auschra; Horst Bickel; Virginie Freytag; Leo Gschwind; Francina Hartmann; Frank Jessen; Hanna Kaduszkiewicz; Wolfgang Maier; Annette Milnik; Michael Pentzek; Steffi G Riedel-Heller; Klara Spalek; Christian Vogler; Michael Wagner; Siegfried Weyerer; Steffen Wolfsgruber; Dominique J-F de Quervain; Andreas Papassotiropoulos
Journal:  JAMA Psychiatry       Date:  2015-10       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.